{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:23:00Z","timestamp":1778826180463,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.09.029","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T14:21:03Z","timestamp":1537885263000},"page":"6591-6593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France"],"prefix":"10.1016","volume":"36","author":[{"given":"Rolf","family":"Kramer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Duclos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Lina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Sebastien","family":"Casalegno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9725","key":"10.1016\/j.vaccine.2018.09.029_b0005","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.029_b0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ppul.23570","article-title":"Respiratory syncytial virus hospitalization and mortality: systematic review and meta-analysis","volume":"52","author":"Stein","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.029_b0015","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.3.17-00163","article-title":"Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015","volume":"23","author":"Jepsen","year":"2018","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.029_b0020","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2013-0303","article-title":"Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age","volume":"132","author":"Hall","year":"2013","journal-title":"Pediatrics"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2018.09.029_b0025","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/infdis\/jit484","article-title":"Importance of global surveillance for respiratory syncytial virus","volume":"208","author":"Iwane","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.029_b0030","article-title":"Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25\u201326 April 2016","author":"Giersing","year":"2017","journal-title":"Vaccine"},{"issue":"May","key":"10.1016\/j.vaccine.2018.09.029_b0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcv.2018.02.004","article-title":"Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014","volume":"102","author":"Gaymard","year":"2018","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.029_b0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/icvts\/ivw278","article-title":"Clinical outcomes and direct costs after transcatheter aortic valve implantation in French centres: a longitudinal study of 1332 patients using a national database","volume":"23","author":"Armoiry","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"11","key":"10.1016\/j.vaccine.2018.09.029_b0045","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/jp.2016.113","article-title":"Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants","volume":"36","author":"McLaurin","year":"2016","journal-title":"J Perinatol"},{"key":"10.1016\/j.vaccine.2018.09.029_b0050","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S2468-2667(17)30103-2","article-title":"Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England","volume":"2","author":"Cromer","year":"2017","journal-title":"Lancet Pub Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:10Z","timestamp":1759400890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":10,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18312891"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}